Pharmacy Manual (OBX319-301)
π Part of the OBX-319 Regulatory Dossier β Reader's Guide. This article shows the live document; edits to the source appear here automatically.
This is a mock / simulation document, made for a portfolio and for learning. The drug (GLPI-103), the sponsor, the people, and the data are all fictional. It is not a real regulatory submission and has no clinical, legal, or regulatory standing. What is real is the shape of the thing β the document structure, the standards it follows, and the analysis methods; the content inside is illustrative.
What it is. Pharmacy Manual (OBX319-301)
Why it exists. An operational trial document describing how the trial is run.
How it is produced here. It is an operational trial document β a plan, charter, or template of the kind kept in the Trial Master File. It describes how the trial is run, rather than reporting the trial's results.
Format & governing standard. β
Pharmacy Manual (OBX319-301)
Document ID: TMF-010
Version: 1.0
Change History: 1.0 β Initial issue.
Standard(s): ICH E6(R3)
Pharmacy Manual β OBX319-301
Instructions for the site pharmacy in OBX319-301: receipt, storage (per the Module 3 conditions), accountability, preparation and subcutaneous administration of OBX-319, blinding handling, and return/destruction. ICH E6(R3); GMP Annex 13/IMP.
No comments yet. Be the first to say something!